California NanoSystems Institute
Text Size: A A A A

Donatello Telesca, Ph.D.

Assistant Professor, Biostatistics
Member, California NanoSystems Institute

Ph.D., University of Washington, Seattle, WA, 2007
M.S., University of Washington, Seattle, WA, 2004
B.S., Bocconi University, Milano, Italy, 2002

Certification Type:
UCLA School of Public Health

Contact Information:
Email Address:
Work Address: 21-254B CHS
Los Angeles, CA 90095
Home Page:
Physician Profile:
Fax Number: (310) 267-2113
Work Phone Number: (310) 825-6402
Research Interests:

My research interests include: Bayesian Inference, Bayesian Model Determination, Bioinformatics, Convolution Models, Cancer Research, Decision Theory, Dependent Data, Functional Data Analysis, Markov Chain Monte Carlo Methods, Non-parametric Models,and Nanoinformatics.

Selected Publications:

Yu EY, Gulati R, Telesca D, Jiang P, Tam S, Russell KJ, Nelson PS, Etzioni RD, Higano CS, Duration of first off-treatment interval is prognostic for time to castration resistance and death in men with biochemical relapse of prostate cancer treated on a prospective trial of intermittent androgen deprivation, J Clin Oncol, 2010, 28 (16), 2668-73.
Telesca D, Inoue LY, Neira M, Etzioni R, Gleave M, Nelson C, Differential expression and network inferences through functional data modeling, Biometrics, 2009, 65 (3), 793-804.
Telesca D. and Inoue L.Y.T., Bayesian Hierarchical Curve Registration, JASA, 2008, 103 (481), 328-339.
Telesca D. Etzioni R. and Gulati R., Estimating Lead Time and Overdiagnosis Associated with PSA Screening from Prostate Cancer Incidence Trends, Biometrics, 2008, 64, 10-19.
Sim HG, Telesca D, Culp SH, Ellis WJ, Lange PH, True LD, Lin DW, Tertiary Gleason pattern 5 in Gleason 7 prostate cancer predicts pathological stage and biochemical recurrence, J Urol, 2008, 179 (5), 1775-9.
Sim H.G., Telesca D., Culp S.H., Lange P.H., Ellis W.J., True L.D., Lin D.W., Cancer to total prostate volume ratio inuences pathological parameter and biochemical recurrence in localized Prostate Cancer treated by radical prostatectomy, Journal of Urology, 2007, 177, 140-141.